BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37877896)

  • 1. Fatal brainstem injury following proton radiation in a patient with medulloblastoma and a germline variant in RNF213.
    Klawinski DM; Cottrell CE; Schieffer KM; Indyk JA; Gandhi K; Mardis ER; Rodriguez DP; Breneman JC; Osorio DS
    Pediatr Blood Cancer; 2024 Jan; 71(1):e30739. PubMed ID: 37877896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of Acute and Late Brainstem Toxicities With Dose-Volume Data for Pediatric Patients With Posterior Fossa Malignancies.
    Nanda RH; Ganju RG; Schreibmann E; Chen Z; Zhang C; Jegadeesh N; Cassidy R; Deng C; Eaton BR; Esiashvili N
    Int J Radiat Oncol Biol Phys; 2017 Jun; 98(2):360-366. PubMed ID: 28463155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of the RNF213 p.R4810K variant may indicate a severe form of pediatric moyamoya disease in Japanese patients.
    Hara S; Mukawa M; Akagawa H; Thamamongood T; Inaji M; Tanaka Y; Maehara T; Kasuya H; Nariai T
    J Neurosurg Pediatr; 2022 Jan; 29(1):48-56. PubMed ID: 34624841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brainstem Injury in Pediatric Patients Receiving Posterior Fossa Photon Radiation.
    Devine CA; Liu KX; Ioakeim-Ioannidou M; Susko M; Poussaint TY; Huisman TAGM; Aboian M; Brown D; Zaslowe-Dude C; Rao AD; Orlina LT; Rawal B; Mueller S; Marcus KJ; Terezakis SA; Braunstein SE; Haas-Kogan DA
    Int J Radiat Oncol Biol Phys; 2019 Dec; 105(5):1034-1042. PubMed ID: 31472183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early onset of moyamoya syndrome in a Down syndrome patient with the genetic variant RNF213 p.R4810K.
    Chong PF; Ogata R; Kobayashi H; Koizumi A; Kira R
    Brain Dev; 2015 Sep; 37(8):822-4. PubMed ID: 25547042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of RNF213 polymorphism on clinical features and long-term outcome in moyamoya disease.
    Kim EH; Yum MS; Ra YS; Park JB; Ahn JS; Kim GH; Goo HW; Ko TS; Yoo HW
    J Neurosurg; 2016 May; 124(5):1221-7. PubMed ID: 26430847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moyamoya Disease and Spectrums of RNF213 Vasculopathy.
    Bang OY; Chung JW; Kim DH; Won HH; Yeon JY; Ki CS; Shin HJ; Kim JS; Hong SC; Kim DK; Koizumi A
    Transl Stroke Res; 2020 Aug; 11(4):580-589. PubMed ID: 31650369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Posterior circulation involvement and collateral flow pattern in moyamoya disease with the RNF213 polymorphism.
    Kim WH; Kim SD; Nam MH; Jung JM; Jin SW; Ha SK; Lim DJ; Lee HB
    Childs Nerv Syst; 2019 Feb; 35(2):309-314. PubMed ID: 30283986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moyamoya vasculopathy shows a genetic mutational gradient decreasing from East to West.
    Raso A; Biassoni R; Mascelli S; Nozza P; Ugolotti E; Di Marco E; De Marco P; Merello E; Cama A; Pavanello M; Capra V
    J Neurosurg Sci; 2020 Apr; 64(2):165-172. PubMed ID: 27787485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of atherosclerotic-moyamoya syndrome with genetic variant of RNF213 p.R4810K and p.T1727M: A case report.
    Liu Y; Wu X; Fan Z; Cheng J; Zhong L; Lin Y; Qu X
    Clin Neurol Neurosurg; 2018 May; 168():163-166. PubMed ID: 29567577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial moyamoya disease in two Turkish siblings with same polymorphism in RNF213 gene but different clinical features.
    Bayram AK; Yilmaz E; Per H; Ito M; Uchino H; Doganay S; Houkin K; Unal E
    Childs Nerv Syst; 2016 Mar; 32(3):569-73. PubMed ID: 26277359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new horizon of moyamoya disease and associated health risks explored through RNF213.
    Koizumi A; Kobayashi H; Hitomi T; Harada KH; Habu T; Youssefian S
    Environ Health Prev Med; 2016 Mar; 21(2):55-70. PubMed ID: 26662949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between moyamoya syndrome and the RNF213 c.14576G>A variant in patients with neurofibromatosis Type 1.
    Phi JH; Choi JW; Seong MW; Kim T; Moon YJ; Lee J; Koh EJ; Ryu SK; Kang TH; Bang JS; Oh CW; Park SS; Lee JY; Wang KC; Kim SK
    J Neurosurg Pediatr; 2016 Jun; 17(6):717-22. PubMed ID: 26849809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNF213 Rare Variants in Slovakian and Czech Moyamoya Disease Patients.
    Kobayashi H; Brozman M; Kyselová K; Viszlayová D; Morimoto T; Roubec M; Školoudík D; Petrovičová A; Juskanič D; Strauss J; Halaj M; Kurray P; Hranai M; Harada KH; Inoue S; Yoshida Y; Habu T; Herzig R; Youssefian S; Koizumi A
    PLoS One; 2016; 11(10):e0164759. PubMed ID: 27736983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rare and Low-Frequency Variants in RNF213 Confer Susceptibility to Moyamoya Syndrome Associated with Hyperthyroidism.
    Nomura S; Akagawa H; Yamaguchi K; Ishikawa T; Kawashima A; Kasuya H; Mukawa M; Nariai T; Maehara T; Okada Y; Kawamata T
    World Neurosurg; 2019 Jul; 127():e460-e466. PubMed ID: 30922903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNF213 variant in a patient with Legius syndrome associated with moyamoya syndrome.
    Romanisio G; Chelleri C; Scala M; Piccolo G; Carlini B; Gatti L; Capra V; Zara F; Bersano A; Pavanello M; De Marco P; Diana MC
    Mol Genet Genomic Med; 2021 Jun; 9(6):e1669. PubMed ID: 33939317
    [No Abstract]   [Full Text] [Related]  

  • 17. Early vasculopathy following radiation in a child with medulloblastoma.
    Maher CO; Raffel C
    Pediatr Neurosurg; 2000 May; 32(5):255-8. PubMed ID: 10965272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNF213 as the major susceptibility gene for Chinese patients with moyamoya disease and its clinical relevance.
    Zhang Q; Liu Y; Zhang D; Wang R; Zhang Y; Wang S; Yu L; Lu C; Liu F; Zhou J; Zhang X; Zhao J
    J Neurosurg; 2017 Apr; 126(4):1106-1113. PubMed ID: 27128593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of CNS Injury for a Cohort of 111 Patients Treated With Proton Therapy for Medulloblastoma: LET and RBE Associations for Areas of Injury.
    Giantsoudi D; Sethi RV; Yeap BY; Eaton BR; Ebb DH; Caruso PA; Rapalino O; Chen YE; Adams JA; Yock TI; Tarbell NJ; Paganetti H; MacDonald SM
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):287-296. PubMed ID: 26691786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNF213 loss-of-function promotes pathological angiogenesis in moyamoya disease via the Hippo pathway.
    Ye F; Niu X; Liang F; Dai Y; Liang J; Li J; Wu X; Zheng H; Qi T; Sheng W
    Brain; 2023 Nov; 146(11):4674-4689. PubMed ID: 37399508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.